|
Fusion gene ID: 34447 |
FusionGeneSummary for SLC39A1_BLK |
Fusion gene summary |
Fusion gene information | Fusion gene name: SLC39A1_BLK | Fusion gene ID: 34447 | Hgene | Tgene | Gene symbol | SLC39A1 | BLK | Gene ID | 27173 | 640 |
Gene name | solute carrier family 39 member 1 | BLK proto-oncogene, Src family tyrosine kinase | |
Synonyms | ZIP1|ZIRTL | MODY11 | |
Cytomap | 1q21.3 | 8p23.1 | |
Type of gene | protein-coding | protein-coding | |
Description | zinc transporter ZIP1solute carrier family 39 (zinc transporter), member 1solute carrier family 39 (zinc transporter), member 3zrt- and Irt-like protein 1 | tyrosine-protein kinase BlkB lymphoid tyrosine kinaseBLK nonreceptor tyrosine kinaseb lymphocyte kinasep55-Blk | |
Modification date | 20180523 | 20180528 | |
UniProtAcc | Q9NY26 | P51451 | |
Ensembl transtripts involved in fusion gene | ENST00000356205, ENST00000368623, ENST00000368621, ENST00000310483, ENST00000537590, ENST00000461071, | ENST00000259089, ENST00000529894, ENST00000525389, | |
Fusion gene scores | * DoF score | 4 X 4 X 3=48 | 4 X 4 X 3=48 |
# samples | 4 | 4 | |
** MAII score | log2(4/48*10)=-0.263034405833794 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(4/48*10)=-0.263034405833794 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: SLC39A1 [Title/Abstract] AND BLK [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Tgene | BLK | GO:0050853 | B cell receptor signaling pathway | 876631 |
Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChiTaRS3.1 | BF743866 | SLC39A1 | chr1 | 153932381 | - | BLK | chr8 | 11406547 | + |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
intron-3CDS | ENST00000356205 | ENST00000259089 | SLC39A1 | chr1 | 153932381 | - | BLK | chr8 | 11406547 | + |
intron-3CDS | ENST00000356205 | ENST00000529894 | SLC39A1 | chr1 | 153932381 | - | BLK | chr8 | 11406547 | + |
intron-intron | ENST00000356205 | ENST00000525389 | SLC39A1 | chr1 | 153932381 | - | BLK | chr8 | 11406547 | + |
intron-3CDS | ENST00000368623 | ENST00000259089 | SLC39A1 | chr1 | 153932381 | - | BLK | chr8 | 11406547 | + |
intron-3CDS | ENST00000368623 | ENST00000529894 | SLC39A1 | chr1 | 153932381 | - | BLK | chr8 | 11406547 | + |
intron-intron | ENST00000368623 | ENST00000525389 | SLC39A1 | chr1 | 153932381 | - | BLK | chr8 | 11406547 | + |
intron-3CDS | ENST00000368621 | ENST00000259089 | SLC39A1 | chr1 | 153932381 | - | BLK | chr8 | 11406547 | + |
intron-3CDS | ENST00000368621 | ENST00000529894 | SLC39A1 | chr1 | 153932381 | - | BLK | chr8 | 11406547 | + |
intron-intron | ENST00000368621 | ENST00000525389 | SLC39A1 | chr1 | 153932381 | - | BLK | chr8 | 11406547 | + |
intron-3CDS | ENST00000310483 | ENST00000259089 | SLC39A1 | chr1 | 153932381 | - | BLK | chr8 | 11406547 | + |
intron-3CDS | ENST00000310483 | ENST00000529894 | SLC39A1 | chr1 | 153932381 | - | BLK | chr8 | 11406547 | + |
intron-intron | ENST00000310483 | ENST00000525389 | SLC39A1 | chr1 | 153932381 | - | BLK | chr8 | 11406547 | + |
intron-3CDS | ENST00000537590 | ENST00000259089 | SLC39A1 | chr1 | 153932381 | - | BLK | chr8 | 11406547 | + |
intron-3CDS | ENST00000537590 | ENST00000529894 | SLC39A1 | chr1 | 153932381 | - | BLK | chr8 | 11406547 | + |
intron-intron | ENST00000537590 | ENST00000525389 | SLC39A1 | chr1 | 153932381 | - | BLK | chr8 | 11406547 | + |
intron-3CDS | ENST00000461071 | ENST00000259089 | SLC39A1 | chr1 | 153932381 | - | BLK | chr8 | 11406547 | + |
intron-3CDS | ENST00000461071 | ENST00000529894 | SLC39A1 | chr1 | 153932381 | - | BLK | chr8 | 11406547 | + |
intron-intron | ENST00000461071 | ENST00000525389 | SLC39A1 | chr1 | 153932381 | - | BLK | chr8 | 11406547 | + |
Top |
FusionProtFeatures for SLC39A1_BLK |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
SLC39A1 | BLK |
Mediates zinc uptake. May function as a major endogenouszinc uptake transporter in many cells of the body. Responsible forthe rapid uptake and accumulation of physiologically effectivezinc in prostate cells. {ECO:0000269|PubMed:12888280}. | Non-receptor tyrosine kinase involved in B-lymphocytedevelopment, differentiation and signaling. B-cell receptor (BCR)signaling requires a tight regulation of several protein tyrosinekinases and phosphatases, and associated coreceptors. Binding ofantigen to the B-cell antigen receptor (BCR) triggers signalingthat ultimately leads to B-cell activation. Signaling through BLKplays an important role in transmitting signals through surfaceimmunoglobulins and supports the pro-B to pre-B transition, aswell as the signaling for growth arrest and apoptosis downstreamof B-cell receptor. Specifically binds and phosphorylates CD79A at'Tyr-188'and 'Tyr-199', as well as CD79B at 'Tyr-196' and 'Tyr-207'. Phosphorylates also the immunoglobulin G receptors FCGR2A,FCGR2B and FCGR2C. With FYN and LYN, plays an essential role inpre-B-cell receptor (pre-BCR)-mediated NF-kappa-B activation.Contributes also to BTK activation by indirectly stimulating BTKintramolecular autophosphorylation. In pancreatic islets, acts asa modulator of beta-cells function through the up-regulation ofPDX1 and NKX6-1 and consequent stimulation of insulin secretion inresponse to glucose. {ECO:0000269|PubMed:19667185,ECO:0000269|PubMed:8756631}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for SLC39A1_BLK |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for SLC39A1_BLK |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for SLC39A1_BLK |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for SLC39A1_BLK |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | SLC39A1 | C0033578 | Prostatic Neoplasms | 2 | CTD_human |
Hgene | SLC39A1 | C0035228 | Respiratory Hypersensitivity | 1 | CTD_human |
Tgene | BLK | C0003873 | Rheumatoid Arthritis | 2 | CTD_human |
Tgene | BLK | C0024141 | Lupus Erythematosus, Systemic | 1 | CTD_human |
Tgene | BLK | C0026691 | Mucocutaneous Lymph Node Syndrome | 1 | CTD_human |